- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01889108
Feasibility Study of SPEEDI (SPEEDI)
August 21, 2023 updated by: Virginia Commonwealth University
Feasibility Study of Supporting Play, Exploration, & Early Development Intervention (SPEEDI) for Infants Born Preterm
The proposed feasibility study will evaluate the investigators ability to conduct a clinical trial of a novel intervention (SPEEDI) which addresses a striking gap in the literature.
Supporting Play, Exploration, and Early Development Intervention (SPEEDI) differs from current early intervention practices in 2 important ways.
First it bridges the traditional gap in services from the Neonatal Intensive Care Unit (NICU) to home providing ongoing and intensive support for developmental activities when parents are establishing care giving routines.
Second, in contrast to wide-ranging intervention provided by current early intervention models, SPEEDI uses an action perception model to target specific behaviors which lead to improved early motor abilities and provide a foundation for learning.[6]
The purpose of this feasibility study is to extend the investigators preliminary data and evaluate the feasibility of conducting a randomized control trial to evaluate the efficacy of SPEEDI.
Study Overview
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Virginia
-
Richmond, Virginia, United States, 23298
- Virginia Commonwealth University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- infants born preterm at 34 weeks Post Menstrual Age (PMA) or less
- medically stable,
- off ventilator support,
- demonstrate thermoregulation in an open crib by 35 weeks of PMA,
- live within 60 minutes of the hospital, and
- have one parent who is English speaking and willing to participate in the study intervention and assessments
Exclusion Criteria:
- genetic syndrome or
- musculoskeletal deformity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
Usual care
|
|
Experimental: Intervention group
Intervention with SPEEDI
|
Behavior intervention combining parent education and physical therapy intervention for preterm infants
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Test of Infant Motor Performance
Time Frame: Change from baseline to the end of intervention at 3 months of adjusted age
|
Assessment of motor development
|
Change from baseline to the end of intervention at 3 months of adjusted age
|
Problem Solving Behaviors
Time Frame: end of intervention at 3 months of adjusted age
|
Early infant problem solving
|
end of intervention at 3 months of adjusted age
|
Reaching
Time Frame: end of intervention at 3 months of adjusted age
|
Reaching and object interaction measures
|
end of intervention at 3 months of adjusted age
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Parent Child Interactions
Time Frame: End of intervention at 3 months of adjusted age
|
Behavioral coding of parent child interactions
|
End of intervention at 3 months of adjusted age
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2012
Primary Completion (Actual)
May 1, 2013
Study Completion (Actual)
June 1, 2013
Study Registration Dates
First Submitted
June 13, 2013
First Submitted That Met QC Criteria
June 27, 2013
First Posted (Estimated)
June 28, 2013
Study Record Updates
Last Update Posted (Actual)
August 22, 2023
Last Update Submitted That Met QC Criteria
August 21, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- VCU_HM13949
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature
-
Ascendance BiomedicalCompletedInfertility | Menopause | Menopause, Premature | Infertility, Female | Premature Ovarian Failure | Menopause Related Conditions | Perimenopausal Disorder | Infertility Unexplained | Menopause Premature Symptomatic | Menopause Premature Asymptomatic | Premature Ovarian Failure, Familial | Premature Ovarian Failure... and other conditionsUnited States
-
Forever Young d.o.o.Medigroup Health System, Jevremova hospital; Saint James Hospital Malta; Re-medika...UnknownMenopause | Menopause, Premature | Premature Ovarian Failure | Ovarian Failure, Premature | Ovarian Failure | Ovarian Insufficiency | Ovarian Insufficiency, Primary | Premature Ovarian Failure 2A | Premature Ovarian Failure 3 | Premature Ovarian Failure 4 | Premature Ovarian Failure 1 | Premature Ovarian Failure... and other conditionsMalta, North Macedonia, Serbia
-
GlaxoSmithKlineCompletedObstetric Labour, Premature | Premature LaborUnited States
-
Assistance Publique Hopitaux De MarseilleUnknownPremature LabourFrance
-
Assiut UniversityNot yet recruitingPremature Rupture of Membrane
-
Cairo UniversityCompletedPremature Rupture of MembraneEgypt
-
University of OklahomaIndiana University School of MedicineCompletedPreterm Premature Rupture of Membranes
-
University of CalgaryCanadian Institutes of Health Research (CIHR); Alberta Economic Development...TerminatedMicrobiota | Gastrointestinal Microbiome | Infant, Premature | Infants, Extremely PrematureCanada
-
Ain Shams UniversityUnknownRupture of Membranes; PrematureEgypt
-
sarah mohamed hassanHend Mostafa Hussein SalemCompletedPremature Rupture of MembraneEgypt
Clinical Trials on SPEEDI
-
Virginia Commonwealth UniversityFoundation for Physical Therapy, Inc.; Children's Hospital FoundationCompletedInfant, Premature, Diseases | Brain White Matter Disease PeriventricularUnited States
-
University of Southern CaliforniaNational Institutes of Health (NIH)Active, not recruitingDoes Timing Matter? Supporting Play, Exploration, and Early Developmental Intervention (TimeSPEEDI2)Cerebral Palsy | Preterm InfantUnited States
-
JDWNRHNot yet recruitingInfant, PrematureBhutan
-
University of Southern CaliforniaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingCerebral Palsy | Hypoxic-Ischemic EncephalopathyUnited States